Structures by: Stowell J. G.
Total: 10
3-(4-Nitroanilino)cyclopent-2-en-1-one
C11H10N2O3
Acta Crystallographica Section C (1997) 53, 11 1717-1719
a=8.2725(7)Å b=13.2730(10)Å c=9.5548(7)Å
α=90° β=97.510(6)° γ=90°
[8S-[7[R*(R*)],8R*]]-7-[2-[[1-(ethoxycarbonyl)-3- phenylpropyl]-amino]-1-oxopropyl]-1,4-dithia-7- azaspiro[4.4]nonane-8-carboxylic acid hydrochloride
C22H31N2O5S2,Cl1,H2O1
Acta Crystallographica Section C (1997) 53, 12 1917-1919
a=10.5075(15)Å b=10.6251(15)Å c=23.407(3)Å
α=90.00° β=90.00° γ=90.00°
C24H39NaO5,C2H6O1
C24H39NaO5,C2H6O1
Acta Crystallographica Section C (1996) 52, 2 325-328
a=7.7383(17)Å b=15.098(2)Å c=22.515(5)Å
α=90° β=90° γ=90°
α-indomethacin
C19H16ClNO4
Journal of the American Chemical Society (2002) 124, 50 15012-15019
a=5.4616(16)Å b=25.310(9)Å c=18.152(7)Å
α=90.00° β=94.38(3)° γ=90.00°
Vitamine B1
C12H20Cl2N4O2S
Crystal Growth & Design (2003) 3, 6 997
a=6.9928(2)Å b=20.6631(10)Å c=11.7695(5)Å
α=90.00° β=98.699(2)° γ=90.00°
Vitamine B1
C12H18Cl2N4OS
Crystal Growth & Design (2003) 3, 6 997
a=7.0994(6)Å b=19.808(2)Å c=11.6378(11)Å
α=90.00° β=101.529(6)° γ=90.00°
?
C34H42N8Ni2O8
Inorganic Chemistry (1999) 38, 2071-2078
a=13.8490(4)Å b=13.6093(4)Å c=19.5583(5)Å
α=90.00° β=92.336(2)° γ=90.00°
?
C34H44B2Cu2F8N6O2
Inorganic Chemistry (1999) 38, 2071-2078
a=9.1471(4)Å b=10.3753(3)Å c=10.5352(5)Å
α=107.200(3)° β=91.193(2)° γ=105.052(3)°
?
C17H22BCuF4N3O
Inorganic Chemistry (1999) 38, 2071-2078
a=9.158(2)Å b=10.714(2)Å c=19.085(4)Å
α=90.00° β=90.582(15)° γ=90.00°
?
C17H22ClCuN3O
Inorganic Chemistry (1999) 38, 2071-2078
a=11.738(3)Å b=14.503(4)Å c=19.731(4)Å
α=90.00° β=90.00° γ=90.00°